ClearPoint Neuro, Inc. (CLPT) — Stock Score Summary

ClearPoint Neuro, Inc. (CLPT) has a MoatMap StockRank of 9/100 based on Quality (30/100), Value (35/100), and Momentum (26/100) factor scores. The current signal is STRONG SELL. ClearPoint Neuro has a strong niche in MRI-guided neurosurgery and is expanding its biologics/drug delivery business, which could tie into the CDMO/biotech innovation cycle. However, it remains unprofitable with a high valuation, failing the Lynch PEG and Buffett margin of safety criteria for now.

ClearPoint Neuro, Inc. develops and commercializes a neuro-navigation system for minimally invasive brain procedures, alongside a portfolio of specialized therapeutic and drug delivery platforms. Its proprietary ClearPoint system offers real-time MRI-guided navigation, providing surgeons with enhanced precision and control for complex neurological interventions. The company is a specialized medical technology firm focusing on advanced neurosurgical solutions, becoming a key enabler for brain drug and gene delivery.

Key Financial Metrics

Price$13.30
Market Cap$367M
P/E (Forward)-12.57
Price/Book18.82
Return on Equity-149.7%
Return on Invested Capital-26.6%
Debt/Equity337.50
Gross Margin62.3%
Operating Margin-69.9%
Revenue Growth42.9%
Free Cash Flow$-12M

ClearPoint Neuro, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is ClearPoint Neuro, Inc.’s (CLPT) StockRank?
MoatMap’s StockRank for ClearPoint Neuro, Inc. (CLPT) is 9/100, with a Strong Sell signal. It is a composite of Quality (30), Value (35), and Momentum (26) factor ranks across MoatMap’s 19,000+ stock universe.
Does ClearPoint Neuro, Inc. have an economic moat?
ClearPoint Neuro, Inc. (CLPT) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ClearPoint Neuro, Inc. a buy, hold, or sell?
MoatMap’s current signal for ClearPoint Neuro, Inc. (CLPT) is Strong Sell, based on a StockRank of 9/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ClearPoint Neuro, Inc. in?
ClearPoint Neuro, Inc. (CLPT) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksCLPT deep dive reportAI ChampionsHow we score stocksSense-check another stock